
watch now
What
Low-cost DNA analysis service providing individuals with access to personalized genetic data to inform health care decisions.
Disrupting
Traditional health-care industry model of reactive patient care.
Source: 23 and Me
Headquarters:Â Mountain View, Calif.
CEO:Â Anne Wojcicki
Year Founded:Â 2006
Number of Employees:Â 92
Funding:Â $126.4 million
Key Investors: Google Ventures, MPM Capital, New Enterprise Associates, Sergey Brin, Esther Dyson, Yuri Milner, Johnson & Johnson Development Corp., the Roche Venture Fund (Genentech)
Vital Stats
- Personal Genome Service is $99 (and requires a little of your saliva)
- Has more than 250,000 genotyped customers
- Goal is 1 million genotyped customers by the end of 2013—the 1 million threshhold is the key to larger genetic discoveries more quickly
- Name refers to the 23 pairs of chromosomes that make up  person's genome
- Has collected 100 million phenotypic data points from surveys to fuel genetic research effortÂ
- Collects 2 million survey responses online each week
- Jimmy Buffett and Warren Buffett, both of them customers, are not closely related, according to DNA analysis
- CEO is the wife of Sergey Brin
On Disruption
Disruptions make people uncomfortable but bring about needed change. I believe 23andMe will disrupt healthcare and fuel genetic discovery.Anne WojcickiCEO and Co-Founder